Drug name - Biktarvy
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7390791 | GILEAD SCIENCES INC | Prodrugs of phosphonate nucleotide analogues |
Apr, 2025
(2 years from now) | |
| US8754065 | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Aug, 2032
(9 years from now) | |
| US9296769 | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Aug, 2032
(9 years from now) | |
| US9732092 | GILEAD SCIENCES INC | Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections |
Dec, 2033
(11 years from now) | |
| US9216996 | GILEAD SCIENCES INC | Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections |
Dec, 2033
(11 years from now) | |
| US9708342 | GILEAD SCIENCES INC | Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olate |
Jun, 2035
(12 years from now) | |
| CN100402539C | GILEAD SCIENCES INC | Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof |
Jul, 2021
(1 year, 2 months ago) | |
| CN1443189A | GILEAD SCIENCES INC | Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof |
Jul, 2021
(1 year, 2 months ago) | |
| CN1706855A | GILEAD SCIENCES INC | Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof |
Jul, 2021
(1 year, 2 months ago) | |
| CN1291994C | GILEAD SCIENCES INC | Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof |
Jul, 2021
(1 year, 2 months ago) | |
| CN110563747A | GILEAD SCIENCES INC | An Anti-Hiv Compound And Its Crystal |
Jun, 2022
(4 months ago) | |
| CN107674086A | GILEAD SCIENCES INC | Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof |
Dec, 2033
(11 years from now) | |
| CN104995198A | GILEAD SCIENCES INC | Polycyclic - Carbamoyl-Pyridone Compounds And Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| CN104995198B | GILEAD SCIENCES INC | Polycyclic Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof |
Dec, 2033
(11 years from now) | |
| CN107674086B | GILEAD SCIENCES INC | Polycyclic-Carbamoyl Pyridone Compounds And Pharmaceutical Use Thereof |
Dec, 2033
(11 years from now) | |
| CN106459085B | GILEAD SCIENCES INC | An Anti-Hiv Compound And Its Crystal |
Jun, 2035
(12 years from now) | |
| CN106459085A | GILEAD SCIENCES INC | (2R, 5S, 13Ar) -7, 9 - -10-((2, 4, 6-Trifluoro-Benzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A - -2, 5-Pyridine Methylene Bridge (1 ', 2 ': 4, 5] Pyridine [2, 1-B] [1, 3] * -8 - Sodium Phenolate |
Jun, 2035
(12 years from now) | |
| IN208435B | GILEAD SCIENCES INC | Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same |
Jul, 2021
(1 year, 2 months ago) | |
| IN200600529P3 | GILEAD SCIENCES INC | Prodrugs Of Phosphonate Nucleotide Analogues |
Jul, 2021
(1 year, 2 months ago) | |
| IN241597B | GILEAD SCIENCES INC | Methoxy Phosphonate Nucleotide Prodrug |
Jul, 2021
(1 year, 2 months ago) | |
| IN200300009P3 | GILEAD SCIENCES INC | Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same |
Jul, 2021
(1 year, 2 months ago) | |
| IN371130B | GILEAD SCIENCES INC | Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| IN201505535P1 | GILEAD SCIENCES INC | Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| IN201918019286A | GILEAD SCIENCES INC | Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| IN352932B | GILEAD SCIENCES INC | Polycyclic Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| EP2682397B1 | GILEAD SCIENCES INC | Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same |
Jul, 2021
(1 year, 2 months ago) | |
| EP2682397A1 | GILEAD SCIENCES INC | Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same |
Jul, 2021
(1 year, 2 months ago) | |
| EP1301519A2 | GILEAD SCIENCES INC | Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same |
Jul, 2021
(1 year, 2 months ago) | |
| EP1301519B1 | GILEAD SCIENCES INC | Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same |
Jul, 2021
(1 year, 2 months ago) | |
| EP2744810B1 | GILEAD SCIENCES INC | Tenofovir Alafenamide Hemifumarate |
Aug, 2032
(9 years from now) | |
| EP2744810A1 | GILEAD SCIENCES INC | Tenofovir Alafenamide Hemifumarate |
Aug, 2032
(9 years from now) | |
| EP3067358A1 | GILEAD SCIENCES INC | Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| EP3608325A1 | GILEAD SCIENCES INC | Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| EP3067358B1 | GILEAD SCIENCES INC | Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| EP3608325B1 | GILEAD SCIENCES INC | Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| EP2822954A1 | GILEAD SCIENCES INC | Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| EP2822954B1 | GILEAD SCIENCES INC | Polycyclic-Carbamoylpyridone Compounds And Their Pharmaceutical Use |
Dec, 2033
(11 years from now) | |
| EP3157932B1 | GILEAD SCIENCES INC | Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate |
Jun, 2035
(12 years from now) | |
| EP3157932A1 | GILEAD SCIENCES INC | Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate |
Jun, 2035
(12 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US7390791
(Pediatric) | GILEAD SCIENCES INC | Prodrugs of phosphonate nucleotide analogues |
Oct, 2025
(3 years from now) | |
|
US8754065
(Pediatric) | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Feb, 2033
(10 years from now) | |
|
US9296769
(Pediatric) | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Feb, 2033
(10 years from now) | |
| US10385067 | GILEAD SCIENCES INC | Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate |
Jun, 2035
(12 years from now) | |
| US10548846 | GILEAD SCIENCES INC | Therapeutic compositions for treatment of human immunodeficiency virus |
Nov, 2036
(14 years from now) | |
Treatment: Treatment of hiv infection
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 30MG BASE;120MG;EQ 15MG BASE | TABLET;ORAL | Prescription |
| EQ 50MG BASE;200MG;EQ 25MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.